• Title of article

    Interleukin-8 promotes cell migration through integrin αvβ6 upregulation in colorectal cancer

  • Author/Authors

    Sun، نويسنده , , Qi and Sun، نويسنده , , Fengkai and Wang، نويسنده , , Ben S.C. Liu، نويسنده , , Song and Niu، نويسنده , , Weibo and Liu، نويسنده , , Enyu and Peng، نويسنده , , Cheng and Wang، نويسنده , , Jiayong and Gao، نويسنده , , Huijie and Liang، نويسنده , , Benjia and Niu، نويسنده , , Zhengchuan and Zou، نويسنده , , Xueqing and Niu، نويسنده , , Jun، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2014
  • Pages
    9
  • From page
    245
  • To page
    253
  • Abstract
    Colorectal cancer (CRC), which is notorious for high morbidity and mortality around the world, shows a predilection for metastasis to liver. Interleukin-8 (IL-8), a chemokine with a defining CXC amino acid motif, has been reported to promote CRC cell migration and is associated with poor prognosis of CRC. However, the underlying molecular mechanism of IL-8-mediated migration remains obscure. In this study, we first demonstrated the cross talk between IL-8 and integrin αvβ6. We analyzed 139 human CRC samples, and found that the immunohistochemical expression of αvβ6 was significantly correlated with expression of IL-8. Furthermore, IL-8 increased the migration through integrin αvβ6 in human CRC cells, and both CXCR1 and CXCR2 were primarily involved during the process. IL-8 upregulated αvβ6 expression in a dose-dependent manner through activation of ERK and Ets-1 signaling pathway. Taken together, our results indicated that IL-8 enhances the migration of CRC cells by increasing αvβ6 integrin expression through the ERK/Ets-1 pathway. Targeting integrin αvβ6 in IL-8 expressing tumors might be a potential therapeutic strategy for CRC patients.
  • Keywords
    interleukin-8 , Colorectal Cancer , Migration , integrin ?v?6
  • Journal title
    Cancer Letters
  • Serial Year
    2014
  • Journal title
    Cancer Letters
  • Record number

    1825200